HSA — authorised 25 November 2019
- Marketing authorisation holder: GLOBAL BLOOD THERAPEUTICS INC
- Status: likely_approved
🇸🇬 Oxbryta in Singapore
HSA authorised Oxbryta on 25 November 2019
Marketing authorisation
Oxbryta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Singapore
Frequently asked questions
Is Oxbryta approved in Singapore?
Yes. HSA authorised it on 25 November 2019.
Who is the marketing authorisation holder for Oxbryta in Singapore?
GLOBAL BLOOD THERAPEUTICS INC holds the Singaporean marketing authorisation.